telemedicine
The Cue Health-sponsored ImmunoCare study is testing the value of giving immunocompromised people at-home tests, telemedicine, and prescription delivery.
23andMe Fiscal Q2 Revenues Grow 37 Percent as Firm Leans Into DTC Primary Care Strategy
Telehealth services from the 2021 acquisition of Lemonaid Health fueled much of the growth for 23andMe in the quarter ended Sept. 30.
ACMG Urges Expanded Telegenetics Services to Address Growing Demand, Reduce Health Disparities
In a new policy statement, ACMG wants the US to make permanent the relaxed telehealth rules adopted during the COVID-19 pandemic.
The company reported a 9 percent increase in revenues in FY2023 Q1, despite a higher net loss, as it continues to integrate Lemonaid Health.
The telehealth and telepharmacy services provided through last year's Lemonaid Health acquisition will help 23andMe integrate genetics into patient care.
Nov 10, 2021
23andMe Fiscal Q2 Revenues Increase 7 Percent
Jun 30, 2021
May 13, 2020
May 7, 2020
Jan 16, 2020
Jun 11, 2019
Genome Medical Raises $23M in Series B Financing
Apr 29, 2019
Jan 24, 2019